AVTOZMA
CELLTRION INC.
Quick answers
Is there a shortage of AVTOZMA in Canada?
No. There is no current shortage of AVTOZMA 200MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Avtozma, Actemra & Tyenne (Tocilizumab) Shortage in Canada
Whether tocilizumab — Actemra and its biosimilars Avtozma and Tyenne — is in shortage in Canada right now, what anticipated and avoided shortage reports mean, and what to ask before switching brands.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
ACTEMRA
HOFFMANN-LA ROCHE LIMITED
AVTOZMA
CELLTRION INC.
DIN
02562030
Strength
200MG
Dosage Form
SOLUTION
Route
INTRAVENOUS
Compare with another product →
Shortage History
Other Products from CELLTRION INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
400MG · DIN 02562049
162MG · DIN 02562057
80MG · DIN 02562022
162MG · DIN 02562065
2MG · DIN 02563045
2MG · DIN 02563037
440MG · DIN 02480794
150MG · DIN 02506211
75MG · DIN 02561018
150MG · DIN 02561026
150MG · DIN 02553813
75MG · DIN 02553805